Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
Titel:
Belzutifan for von Hippel-Lindau disease-associated renal cell carcinoma and other neoplasms (LITESPARK-004): 50 months follow-up from a single-arm, phase 2 study
Auteur:
Srinivasan, Ramaprasad Iliopoulos, Othon Beckermann, Kathryn E Narayan, Vivek Maughan, Benjamin L Oudard, Stephane Else, Tobias Maranchie, Jodi K Iversen, Ane B Cornell, Jerry Perini, Rodolfo F Liu, Yanfang Linehan, W Marston Jonasch, Eric